HOUSE-BILL 6171: H.R.6171 - ACA Copay CAP Act of 2025
AI-Powered Summary
HOUSE-BILL 6171 aims to enhance affordability and access to prescription medications by establishing an out-of-pocket limit on annual spending for individuals. This legislation addresses major themes of health care access and consumer protection, particularly for those with chronic conditions or significant medication needs. Key provisions include a cap on out-of-pocket expenses for prescription drugs starting in 2027, with specific dollar amounts for different coverage types that will adjust annually. The bill amends existing provisions of the Patient Protection and Affordable Care Act to incorporate these new limits. Implementation will require health plans to adhere to the new caps, which may raise constitutional questions regarding federal authority over private health plans and the balance of power between federal and state regulations. The potential impacts include reduced financial burdens on individuals, improved health outcomes through better access to necessary medications, and broader implications for health care rights under the Constitution.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill supports the principle of health equity by making medications more affordable, which can positively impact individuals across various demographic categories. It addresses financial burdens that disproportionately affect low-income individuals and marginalized groups, thereby promoting equal protection under the law.
Key Individual Rights
- Right to Health Care (de facto)
- Equal Protection under the Law
Constitutional Provisions
- Equal Protection Clause (14th Amendment)
- Commerce Clause (Article I, Section 8)
Potential Constitutional Challenges Or Support
Challenges
The bill may face scrutiny regarding its effectiveness in addressing disparities in access to medications, particularly for marginalized groups. If the cap does not account for varying medication costs, it could lead to unequal protection.
Support
The bill promotes health equity and encourages preventive care, aligning with the broader goals of the ACA to reduce health disparities.
Summary
HOUSE-BILL 6171 aims to alleviate financial burdens associated with prescription medications by establishing an out-of-pocket limit. Its implications for individual rights and constitutional protections are significant, particularly in promoting health equity and access to necessary medications for diverse demographic groups. The bill's success will depend on its implementation and ability to address the needs of vulnerable populations.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 6171 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
November 20, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat